StockClub

DMAA

DMAADrugs Made In America Acquisition Corp. Ordinary Shares$ --
Drugs Made In America Acquisition Corp. Ordinary Shares

Drugs Made In America Acquisition Corp. Ordinary Shares

DMAA

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 09/30/2025FY2025 Q3
Revenue
0M USD
YoY -
Operating Income
-0M USD
YoY -82.0%
Net Income
2M USD
YoY +1607.3%
EPS
0.07$
YoY +1500.0%

Revenue

$0
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
Actual
$0 (-)

Net Income

$5.7M
FY2024 Q2$-55
$-55
Q2
FY2024 Q3$-144,983
$-144,983
Q3
FY2024 Q4$-145,262
$-145,262
Q4
FY2025 Q1$1.3M
$1.3M
Q1
FY2025 Q2$3.5M
$3.5M
Q2
FY2025 Q3$5.7M
$5.7M
Q3
Actual
+$5.9M (+4050.6%)

Surprise History

Actual RevenueAnalyst Estimate
FY2024
Actual:$0
FY2024
$0

Analyst Estimates

No forecast data